CIRCULATING SOLUBLE LOW DENSITY LIPOPROTEIN RECEPTOR LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS BEFORE AND AFTER STATIN THERAPY

被引:0
|
作者
Ooi, Teik C. [1 ]
Gaudet, Daniel [2 ]
Brisson, Diane [2 ]
Tepliakova, Lioudmila [3 ]
Figeys, Daniel [3 ]
Mayne, Janice [3 ]
机构
[1] Univ Ottawa, Ottawa Hosp Res Inst, Dept Med, Div Endocrinol & Metab, Ottawa, ON, Canada
[2] Univ Montreal, Dept Med, Ecogene 21, Montreal, PQ, Canada
[3] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON, Canada
关键词
D O I
10.1016/j.atherosclerosissup.2018.04.182
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
P1.089
引用
收藏
页码:60 / 61
页数:2
相关论文
共 50 条
  • [1] EFFECTS OF EVOLOCUMAB ON LIPOPROTEIN PARTICLES AND SUBCLASSES IN HYPERCHOLESTEROLEMIC AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS ON STATIN THERAPY
    Xu, Ren
    Dias, Clapton
    Peach, Matt
    Gao, Bing
    Hamilton, Lisa
    Smith, Brian
    Cooke, Blaire
    Jackson, Simon
    Shaywitz, Adam
    Fitzpatrick, Dan
    Scott, Rob
    Wasserman, Scott
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1378 - A1378
  • [2] LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AMONG PATIENTS WITH CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA POST STATIN THERAPY
    Johnson, B. H.
    Bonafede, M. M.
    Princic, N.
    Harrison, D. J.
    Boatman, B.
    Patel, J.
    VALUE IN HEALTH, 2016, 19 (03) : A58 - A58
  • [3] ALTERATIONS IN LOW-DENSITY-LIPOPROTEIN COMPOSITION WITH HYPOLIPIDEMIC THERAPY IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    SUNDBERG, EEM
    ILLINGWORTH, DR
    CLINICAL RESEARCH, 1986, 34 (01): : A65 - A65
  • [4] NORMALIZATION OF LOW-DENSITY-LIPOPROTEIN LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH A COMBINED DRUG REGIMEN
    KANE, JP
    MALLOY, MJ
    TUN, P
    PHILLIPS, NR
    FREEDMAN, DD
    WILLIAMS, ML
    ROWE, JS
    HAVEL, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (05): : 251 - 258
  • [5] Polymorphisms of the low-density lipoprotein receptor gene in Brazilian individuals with heterozygous familial hypercholesterolemia
    Salazar, LA
    Cavalli, SA
    Hirata, MH
    Diament, J
    Forti, N
    Giannini, SD
    Nakandakare, ER
    Bertolami, MC
    Hirata, RDC
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2000, 33 (11) : 1301 - 1304
  • [6] Polymorphisms at the SRBI locus are associated with lipoprotein levels in subjects with heterozygous familial hypercholesterolemia
    Tai, ES
    Adiconis, X
    Ordovas, JM
    Carmena-Ramon, R
    Real, J
    Corella, D
    Ascaso, J
    Carmena, R
    CLINICAL GENETICS, 2003, 63 (01) : 53 - 58
  • [7] Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia
    Miltiadous, George
    Saougos, Vasilios
    Cariolou, Marios
    Elisaf, Moses S.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (03): : 353 - 355
  • [8] EFFECTS OF COLESTIPOL ON LOW-DENSITY-LIPOPROTEIN IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    SUNDBERG, EE
    ILLINGWORTH, DR
    ARTERIOSCLEROSIS, 1987, 7 (05): : A513 - A513
  • [9] Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment
    Omer, Linda
    Hindi, Lubna
    Militello, Giuseppe
    Stivers, Katlin B.
    Tien, Kenneth C.
    Boyd, Nolan L.
    DISEASE MODELS & MECHANISMS, 2020, 13 (04)
  • [10] PLASMA-EXCHANGE AND LOW-DENSITY LIPOPROTEIN FILTRATION THERAPY IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    TIJHUIS, GJ
    VANDOORMAAL, JJ
    RIJSKAMP, L
    SIBINGA, CTS
    DOORENBOS, H
    PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1988, 9 (01): : 29 - 34